2021
The Health and Economic Benefits of Tests That Predict Future Progression to Tuberculosis Disease
Menzies NA, Shrestha S, Parriott A, Marks SM, Hill AN, Dowdy DW, Shete PB, Cohen T, Salomon JA. The Health and Economic Benefits of Tests That Predict Future Progression to Tuberculosis Disease. Epidemiology 2021, 33: 75-83. PMID: 34669631, PMCID: PMC8633045, DOI: 10.1097/ede.0000000000001418.Peer-Reviewed Original ResearchConceptsPositive predictive valueHigh positive predictive valueFuture tuberculosisLatent tuberculosis infection treatmentIncremental costHigher treatment initiationCompletion of treatmentInterferon-gamma releaseQuality-adjusted life yearsTransmission dynamic modelLTBI testingTreatment initiationTreatment acceptanceTuberculosis diseasePrevention servicesPredictive valueTreatment servicesLife yearsTuberculosisInfection treatmentSocietal perspectiveIGRATreatment volumeHealth improvementFuture progression
2020
Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in California
Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay GR, Barry P, Readhead A, Flood J, Kahn JG, Shete PB. Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in California. American Journal Of Respiratory And Critical Care Medicine 2020, 201: 356-365. PMID: 31626560, PMCID: PMC7464931, DOI: 10.1164/rccm.201907-1289oc.Peer-Reviewed Original ResearchConceptsTB incidenceTB casesAdditional interventionsTuberculosis epidemiologyPublic health prioritizationTreatment of LTBIInfection control interventionsPotential intervention effectsLTBI testingTB servicesLTBI diagnosisLTBI prevalenceAverage annual declineEpidemiologic projectionsSustained reductionTreatment interventionsControl interventionsTB determinantsDefinitive dataIntervention effectsAnnual declineLocal transmissionIncidenceLTBIIntervention